NDC 45963-455 – Deferasirox
Deferasirox 250 mg/1 · Tablet, For Suspension · Oral
Product NDC45963-455
Product details
- Brand name
- Deferasirox
- Generic name
- Deferasirox
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- Tablet, For Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA203560
- Marketed since
- March 22, 2019
- Marketing end
- September 30, 2026
- Pharmacologic class
- Iron Chelator
Active ingredients
- Deferasirox 250 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 45963-455-30 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (45963-455-30) | Mar 22, 2019 |
Other Deferasirox products
- 45963-456 Deferasirox 500 mg/1 · Tablet, For Suspension · Actavis Pharma, Inc.
- 62332-324 Deferasirox 125 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Inc.
- 62332-325 Deferasirox 250 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Inc.
- 62332-326 Deferasirox 500 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Inc.
- 46708-325 Deferasirox 250 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Limited
- 46708-324 Deferasirox 125 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Limited
- 46708-326 Deferasirox 500 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Limited
- 67877-550 Deferasirox 250 mg/1 · Tablet, For Suspension · Ascend Laboratories, LLC
- 67877-549 Deferasirox 125 mg/1 · Tablet, For Suspension · Ascend Laboratories, LLC
- 67877-551 Deferasirox 500 mg/1 · Tablet, For Suspension · Ascend Laboratories, LLC
- 69452-160 Deferasirox 250 mg/1 · Tablet, For Suspension · Bionpharma Inc.
- 69452-159 Deferasirox 125 mg/1 · Tablet, For Suspension · Bionpharma Inc.